- Report
- August 2024
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- May 2024
- 137 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- November 2023
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- January 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- August 2022
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- December 2023
- 300 Pages
Global
From €2386EUR$2,500USD£1,999GBP
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
Russia
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
Poland
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
Japan
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
Ireland
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
India
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
Germany
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
France
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
China
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
Brazil
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
Argentina
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2023
- 80 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP

Propylthiouracil (PTU) is a medication used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. It is a thioamide drug, which works by blocking the production of thyroid hormones. PTU is used to treat Graves' disease, an autoimmune disorder that causes hyperthyroidism, as well as other forms of hyperthyroidism. PTU is also used to treat thyroid storm, a rare but serious condition in which the body produces too much thyroid hormone. PTU is part of the Endocrine and Metabolic Disorders Drugs market, which includes medications used to treat a variety of endocrine and metabolic disorders. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders.
Companies in the Propylthiouracil market include Merck, Pfizer, Sanofi, and Mylan. Show Less Read more